{"product_id":"oakstone-cytopathology-2026","title":"Oakstone Cytopathology 2026","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003ch3\u003eOakstone Cytopathology 2026\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 43 videos + 2 pdfs, size: 8.41 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: pathologists needing to improve their understanding and confidence in the diagnosis of cytopathology specimens\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch3\u003eCytopathology to Refine Diagnostic Skills\u003c\/h3\u003e\n\u003cbr\u003eTake your diagnostic skills to the next level with this engaging, practice-focused online course. \u003cem\u003eCytopathology\u003c\/em\u003e — part of our \u003cem\u003eMasters of Pathology Series\u003c\/em\u003e — reviews the latest updates to WHO reporting systems and explores how molecular testing and other ancillary studies are transforming the way small biopsy and cytopathology specimens are assessed.\u003cbr\u003e\u003cbr\u003eGeared towards those who may not have formal training in cytopathology, the succinct, high-yield lectures in this continuing medical education program are divided by specimen type and will help you to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eGain a deeper understanding of how The Bethesda System for Reporting Thyroid Cytopathology has reduced unnecessary surgical interventions\u003c\/li\u003e\n\u003cli\u003eConsistently generate standardized reports that are more useful and better understood by clinicians\u003c\/li\u003e\n\u003cli\u003eAvoid common pitfalls like overinterpreting benign findings or relying too heavily on surgical pathology when results are discordant\u003c\/li\u003e\n\u003cli\u003eConfidently identify benign and reactive findings in cytopathology specimens\u003c\/li\u003e\n\u003cli\u003eAnd more…\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e January 15, 2026\u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cem\u003eAt the completion of this course, you should be able to:\u003c\/em\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eList ancillary tests that should be ordered on lung specimens when a new diagnosis of non-small cell carcinoma is made\u003c\/li\u003e\n\u003cli\u003eDescribe changes made in the newest version of The Bethesda System for Reporting Thyroid Cytopathology\u003c\/li\u003e\n\u003cli\u003eName the diagnostic categories used in The Paris System for Reporting Urinary Cytology\u003c\/li\u003e\n\u003cli\u003eUnderstand situations in which a diagnosis of Salivary Gland of Uncertain Malignant Potential (SUMP) can be made\u003c\/li\u003e\n\u003cli\u003eRecognize the cytomorphologic features of common bone and soft tissue tumors on fine needle aspiration\u003c\/li\u003e\n\u003cli\u003eCompare different methodologies used for human papillomavirus (HPV) testing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\n\u003cbr\u003ePathologists needing to improve their understanding and confidence in the diagnosis of cytopathology specimens.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe Bethesda System for Reporting Thyroid Cytopathology Third Edition – \u003cem\u003ePaul A. VanderLaan, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMolecular Testing in Thyroid FNA Specimens – \u003cem\u003eMichiya Nishino, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThyroid Cytomorphology Part I – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThyroid Cytomorphology Part II – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Thyroid FNA Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Milan System for Reporting Salivary Gland Cytopathology Second Edition – \u003cem\u003eWilliam C. Faquin, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Salivary Gland FNA Cases – \u003cem\u003eZahra Maleki, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eFNA of Lateral Neck Lesions – A Case-Based Approach – \u003cem\u003eDarcy A. Kerr, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eApproach to Liver Cytopathology and Small Biopsies – \u003cem\u003eM. Lisa Zhang, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUpdate on the WHO Reporting System for Pancreaticobiliary Cytopathology – \u003cem\u003eMartha Bishop Pitman, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eFNA Cytology of Solid Pancreatic Lesions – \u003cem\u003eMonica T. Garcia-Buitrago, MD, FCAP\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eApproach to Pancreatic Cyst Cytology – \u003cem\u003eM. Lisa Zhang, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Pancreas FNA Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSerous Cavity I – The International System for Serous Fluid Cytopathology – \u003cem\u003eAshish Chandra, FRCPath, DipRCPath (Cytol)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSerous Cavity II – Pleural Fluid – Malignant Tumors and Mimickers – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSerous Cavity III – Pelvic Washing Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSerous Cavity IV – Challenges Cases – Pelvic Washing Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBone and Soft Tissue (BST) I – The WHO Reporting System for Soft Tissue Cytopathology – \u003cem\u003eIvan Chebib, MD, FRCPC\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBone and Soft Tissue (BST) II – A Pattern-Based Approach – \u003cem\u003eVickie Y. Jo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBone and Soft Tissue (BST) III – An Update on Immunohistochemical Markers – \u003cem\u003eVickie Y. Jo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCytopathology of Bone Tumors – \u003cem\u003eValerie A. Fitzhugh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCytopathology of Soft Tissue Tumors – \u003cem\u003eValerie A. Fitzhugh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe International System for Reporting Lung Cytopathology – \u003cem\u003eFernando Schmitt, MD, PhD, FIAC\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePulmonary I – Cytology of NSCLC – Does Morphology Matter? – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePulmonary II – Lung Tumors other than NSCLC – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePulmonary III – Ancillary Testing in NSCLC: Why, When, and How to Perform? – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePulmonary IV – Non-Neoplastic Pulmonary Cytology: Bugs, BALs, and Beyond – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eKidney I – Fine Needle Aspiration and Small Biopsy Specimens – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eKidney II – Fine Needle Aspiration and Small Biopsy Specimens – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast I – Introduction to the Yokohama System – \u003cem\u003eGary Tse, MBBS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast II – Challenging Cases in Breast Cytology – \u003cem\u003eChristine Noga Booth MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUrine I – The Paris System for Reporting Urinary Cytology – \u003cem\u003eChristopher J. VandenBussche, MD PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUrine II – Benign and Reactive Findings in Urine Specimens – \u003cem\u003eChristopher J. VandenBussche, MD PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUrine III – Neoplastic Findings in Urine Specimens – \u003cem\u003eChristopher J. VandenBussche, MD PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUrine IV – Instructive Urine Cytology Cases – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMiscellaneous FNA Challenge Cases – \u003cem\u003eChristopher J. VandenBussche, MD PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eHPV Biology and Testing in Pap Test Specimens – \u003cem\u003eMichael J. Thrall, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eASCCP Guidelines and the Role of Cytology in Screening – \u003cem\u003eMichael J. Thrall\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954538516578,"sku":"MED-AMB05644","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Oakstone-Cytopathology-2026.jpg?v=1779379268","url":"https:\/\/meducourse.com\/products\/oakstone-cytopathology-2026","provider":"Meducourse","version":"1.0","type":"link"}